712 related articles for article (PubMed ID: 15037985)
21. [The adaptometry study in patients with diabetic retinopathy].
Iliuşi FG; Preda M
Oftalmologia; 2004; 48(1):43-7. PubMed ID: 15279418
[TBL] [Abstract][Full Text] [Related]
22. Differences in retinal neovascular tissue and vitreous humour in patients with type 1 and type 2 diabetes.
Kinnunen K; Puustjärvi T; Teräsvirta M; Nurmenniemi P; Heikura T; Laidinen S; Paavonen T; Uusitalo H; Ylä-Herttuala S
Br J Ophthalmol; 2009 Aug; 93(8):1109-15. PubMed ID: 19304585
[TBL] [Abstract][Full Text] [Related]
23. Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression.
Li L; Renier G
Metabolism; 2006 Nov; 55(11):1516-23. PubMed ID: 17046555
[TBL] [Abstract][Full Text] [Related]
24. A new view of diabetic retinopathy: a neurodegenerative disease of the eye.
Barber AJ
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):283-90. PubMed ID: 12657367
[TBL] [Abstract][Full Text] [Related]
25. [New prospects in the treatment of diabetic retinopathy. Current situation and pharmacological developments].
Lagrèze WA
MMW Fortschr Med; 2003 Apr; 145(14):37-8. PubMed ID: 15072277
[No Abstract] [Full Text] [Related]
26. Does hypertension play a role in diabetic retinopathy?
Srivastava BK; Rema M
J Assoc Physicians India; 2005 Sep; 53():803-8. PubMed ID: 16334627
[TBL] [Abstract][Full Text] [Related]
27. [Effect of argon laser photocoagulation on diabetic retinopathy].
Wei ZY; Hu SX; Tang N; Wu J; Wang J
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1313-5. PubMed ID: 15567792
[TBL] [Abstract][Full Text] [Related]
28. [The role of vascular endothelial growth factor (VEGF)].
Urban B; Peczyńska J
Klin Oczna; 2003; 105(5):319-21. PubMed ID: 14746189
[TBL] [Abstract][Full Text] [Related]
29. [Ocular complications in diabetes: towards standardizing screening and care].
Massin P
Rev Prat; 2001 Oct; 51(16):1776-82. PubMed ID: 11795121
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the role of vascular endothelial growth factor in diabetic retinopathy.
Mahdy RA; Nada WM
Ophthalmic Res; 2011; 45(2):87-91. PubMed ID: 20720438
[TBL] [Abstract][Full Text] [Related]
31. Treating diabetic retinopathy by tackling growth factor pathways.
Chiarelli F; Giannini C; Di Marzio D; Mohn A
Curr Opin Investig Drugs; 2005 Apr; 6(4):395-409. PubMed ID: 15898347
[TBL] [Abstract][Full Text] [Related]
32. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
Matthews DR; Stratton IM; Aldington SJ; Holman RR; Kohner EM;
Arch Ophthalmol; 2004 Nov; 122(11):1631-40. PubMed ID: 15534123
[TBL] [Abstract][Full Text] [Related]
33. [Diabetic retinopathy. Current opinion on pathophysiology, diagnostics and therapy].
Sacha E
Przegl Lek; 2005; 62(4):238-42. PubMed ID: 16229243
[TBL] [Abstract][Full Text] [Related]
34. Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy.
Lee IG; Chae SL; Kim JC
Eye (Lond); 2006 May; 20(5):546-52. PubMed ID: 15905870
[TBL] [Abstract][Full Text] [Related]
35. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
[TBL] [Abstract][Full Text] [Related]
36. High levels of pigment epithelium-derived factor in the retina of a rat model of type 2 diabetes.
Matsuoka M; Ogata N; Minamino K; Higuchi A; Matsumura M
Exp Eye Res; 2006 Jan; 82(1):172-8. PubMed ID: 16054135
[TBL] [Abstract][Full Text] [Related]
37. Update on the treatment of diabetic retinopathy.
Yam JC; Kwok AK
Hong Kong Med J; 2007 Feb; 13(1):46-60. PubMed ID: 17277392
[TBL] [Abstract][Full Text] [Related]
38. [Role of vascular endothelial growth factor in the development of diabetic retinopathy in patients with type 1 diabetes mellitus].
Ermakova NA; Syrodeeva ON; Antsiferov MB; Balatskaia NV; Krasnova LB
Vestn Oftalmol; 2008; 124(1):25-8. PubMed ID: 18318205
[TBL] [Abstract][Full Text] [Related]
39. Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetes.
Spijkerman AM; Gall MA; Tarnow L; Twisk JW; Lauritzen E; Lund-Andersen H; Emeis J; Parving HH; Stehouwer CD
Diabet Med; 2007 Sep; 24(9):969-76. PubMed ID: 17593241
[TBL] [Abstract][Full Text] [Related]
40. Diabetic retinopathy: An update on treatment.
Fante RJ; Durairaj VD; Oliver SC
Am J Med; 2010 Mar; 123(3):213-6. PubMed ID: 20193825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
